お問い合わせフォーム
に入力の上、ご送信ください。詳細は折り返しメールでお伺いしますので簡単で結構です。
構造式をクリックして表示される詳細画面からでもお問い合わせいただけます。
| SCHEM No. | Structure | Compound Name | Price (JPY) | Purity | Stock(mg) |
|---|---|---|---|---|---|
| 06410 |  | Cy7(PEG13-COOH)(PEG3-OMe) | 119,600/0.1mg | >95% | 0.4 |
| 06064 |  | Cy7-NHPEG13-COOtBu | 96,000/0.1mg | >95% | 0 |
| 05373 |  | Alexa 647-CONH-PEG13-CONH-PEG2-O-HexCl | 119,600/0.1mg | >95% | 0.1 |
| 05078 |  | Alexa 647-NH-PEG13-COOtBu | 96,000/0.1mg | >95% | 0 |
| 04731 |  | DY-547-CONH-PEG13-COOH | 69100/<0.1mg | >95% | 0.1 |
| 04727 |  | Cy3-CONH-PEG13-COOH | 64,600/0.1mg | >95% | 0.1 |
| 04726 |  | Cy5-CONH-PEG13-COOH | 69100/<0.1mg | >95% | 0.1 |
| 04721 |  | Cy3-CONH-PEG13-COOtBu | 72,400/0.2mg | >95% | 0.1 |
| 04720 |  | Cy5(Me)(CONH-PEG13-COOtBu) | 72,400/0.2mg | >95% | 1.5 |
| 06062 |  | Cy7-PEG4-COOH | 96,000/0.1mg | >95% | 0.1 |
| 06009 |  | Cy7 PEG4-COOMe | 96,000/0.1mg | >95% | 0 |
| 00207 |  | Cy3-CONH-PEG4-O-Et-CONHPrCOOH | 64,600/0.5mg | >95% | 44.6 |
| 06061 |  | 6-[(2E)-2-[(2E,4E,6E)-7-[1-[2-(2-acetoxyethoxy)ethyl]-3,3-dimethyl-5-sulfo-indol-2-yl]hepta-2,4,6-trienylidene]-3,3-dimethyl-indolin-1-yl]hexanoic acid | 96,000/0.1mg | >95% | 0.1 |
| 01331 |  | Cy5-NH-PEG3-NH2 | 63,300/0.9mg | >95% | 0 |
| 06523 |  | 1-[2-(carboxymethoxy)ethyl]-2-[(1E,3E,5E,7E)-7-[1-[2-(carboxymethoxy)ethyl]-3,3-dimethyl-5-sulfo-indolin-2-ylidene]-4-(2-sulfoethyl)hepta-1,3,5-trienyl]-3,3-dimethyl-indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06522 |  | (3S)-1-(5-carboxypentyl)-2-[(1E,3E,5E,7E)-7-[(3R)-1-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]hepta-1,3,5-trienyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06521 |  | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06520 |  | 2-[(1E,3E,5Z)-5-[1,3-bis[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-indolin-2-ylidene]penta-1,3-dienyl]-1-[2-[2-(2-carboxyethoxy)ethoxy]ethyl]-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06519 |  | 1-(5-carboxypentyl)-2-[(1E,3E,5E,7E)-7-[1-ethyl-3-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-3-methyl-5-sulfo-indolin-2-ylidene]hepta-1,3,5-trienyl]-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06518 |  | 2-[(1E,3E,5Z)-5-[1-(5-carboxypentyl)-3,3-dimethyl-5-sulfo-indolin-2-ylidene]penta-1,3-dienyl]-1-ethyl-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06517 |  | 1-(4-aminobutyl)-2-[(1E,3E,5E)-5-[1-(5-carboxypentyl)-3,3-dimethyl-indolin-2-ylidene]penta-1,3-dienyl]-3,3-dimethyl-indol-1-ium-5-sulfonate | 119,600/0.1mg | >95% | 0 |
| 06516 |  | (3R)-2-[(1E,3E,5E)-5-[(3S)-1-(5-carboxypentyl)-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]penta-1,3-dienyl]-1-[2-(2-methoxyethoxy)ethyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06515 |  | 2-[(E,3E)-3-[3,3-dimethyl-5-sulfo-1-[2-[2-(4-sulfobutoxy)ethoxy]ethyl]indolin-2-ylidene]prop-1-enyl]-3,3-dimethyl-1-[2-[2-(4-sulfobutoxy)ethoxy]ethyl]indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06514 |  | 1-ethyl-2-[(E,3E)-3-[1-[6-(2-hydroxyethoxy)-6-oxo-hexyl]-3,3-dimethyl-5-sulfo-indolin-2-ylidene]prop-1-enyl]-3,3-dimethyl-indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06513 |  | 3-[2-[(1E,3E,5Z)-5-[3,3-dimethyl-5-sulfo-1-(3-sulfopropyl)indolin-2-ylidene]penta-1,3-dienyl]-3-[5-[2-(2-hydroxyethoxy)ethylamino]-5-oxo-pentyl]-3-methyl-5-sulfo-indol-1-ium-1-yl]propane-1-sulfonate | inquire | >95% | 0 |
| 06512 |  | 3-(5-carboxypentyl)-1-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethyl]-2-[(1E,3E,5E)-5-[3-(2-methoxyethyl)-1-methyl-1-(3-sulfopropyl)benzo[e]indol-2-ylidene]penta-1,3-dienyl]-1-methyl-8-sulfo-benzo[e]indol-3-ium-6-sulfonate | inquire | >95% | 0 |
| 06511 |  | 3-(5-carboxypentyl)-1-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethyl]-2-[(1E,3E,5E)-5-[3-(2-methoxyethyl)-1-methyl-1-(3-sulfopropyl)benzo[e]indol-2-ylidene]penta-1,3-dienyl]-1-methyl-8-sulfo-benzo[e]indol-3-ium-6-sulfonate | inquire | >95% | 0 |
| 06510 |  | 3-[2-[(1E,3E,5E,7Z)-7-[3,3-dimethyl-5-sulfo-1-(3-sulfopropyl)indolin-2-ylidene]hepta-1,3,5-trienyl]-3-[6-[2-(2-methoxyethoxy)ethylamino]-6-oxo-hexyl]-3-methyl-5-sulfo-indol-1-ium-1-yl]propane-1-sulfonate | inquire | >95% | 0 |
| 06509 |  | 1-(5-carboxypentyl)-2-[(E,3Z)-3-[1-ethyl-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-indolin-2-ylidene]prop-1-enyl]-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06477 |  | Cy5(CH2-COOtBu)(Hex-COOH) | 119,600/0.1mg | >95% | 1.1 |
| 06446 |  | 3-[2-[2-[(2E)-2-[(E)-3-[3,3-dimethyl-1-[2-[2-(3-sulfopropoxy)ethoxy]ethyl]indol-1-ium-2-yl]prop-2-enylidene]-3,3-dimethyl-indolin-1-yl]ethoxy]ethoxy]propane-1-sulfonic acid | inquire | >95% | 0 |
| 06440 |  | (3R)-1-(5-carboxypentyl)-2-[(1E,3E,5E,7E)-7-[(3R)-1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]hepta-1,3,5-trienyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06439 |  | 1-(5-carboxypentyl)-2-[(1E,3E,5Z)-5-[1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]penta-1,3-dienyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06438 |  | Cy7 | 119,600/0.1mg | >95% | 0 |
| 06434 |  | 2-[(E,3Z)-3-[1,3-bis[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-indolin-2-ylidene]prop-1-enyl]-1-[2-[2-(2-carboxyethoxy)ethoxy]ethyl]-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06433 |  | 1-(5-carboxypentyl)-2-[(1E,3E,5E)-5-[1-ethyl-3-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-3-methyl-5-sulfo-indolin-2-ylidene]penta-1,3-dienyl]-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06432 |  | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06431 |  | 2-[(1E,3E,5E,7E)-7-[1-(5-carboxypentyl)-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]hepta-1,3,5-trienyl]-1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06430 |  | 2-[(1E,3E,5E)-5-[1-(5-carboxypentyl)-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]penta-1,3-dienyl]-1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06429 |  | 2-[(1E,3E,5Z)-5-[1-(5-carboxypentyl)-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]penta-1,3-dienyl]-1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06428 |  | 2-[(1E,3E,5Z)-5-[1-(5-carboxypentyl)-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]penta-1,3-dienyl]-1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06427 |  | (3R)-2-[(1E,3E,5E)-5-[(3R)-1-(5-carboxypentyl)-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]penta-1,3-dienyl]-1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06426 |  | (3S)-1-(5-carboxypentyl)-2-[(1E,3E,5E,7E)-7-[(3R)-1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]hepta-1,3,5-trienyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06425 |  | 2-[(1Z,3E,5E,7E)-7-[1-(5-carboxypentyl)-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]hepta-1,3,5-trienyl]-1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06423 |  | 2-[(1E,3E,5E,7E)-7-[1-(5-carboxypentyl)-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]hepta-1,3,5-trienyl]-1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06422 |  | (3R)-2-[(1E,3E,5E)-5-[(3S)-1-(5-carboxypentyl)-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]penta-1,3-dienyl]-1-[2-(2-methoxyethoxy)ethyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06421 |  | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06420 |  | (3R)-1-(5-carboxypentyl)-2-[(E,3E)-3-[(3S)-1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06419 |  | (3R)-2-[(1E,3E,5E)-5-[(3S)-1-(5-carboxypentyl)-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]penta-1,3-dienyl]-1-[2-(2-methoxyethoxy)ethyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06418 |  | 3-[2-[2-[2-[(1E,3E,5E,7Z)-7-[1,3-bis[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-indolin-2-ylidene]hepta-1,3,5-trienyl]-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-indol-1-ium-1-yl]ethoxy]ethoxy]propanoic acid | inquire | >95% | 0 |
| 06417 |  | (3S)-1-(5-carboxypentyl)-2-[(1E,3E,5E,7E)-7-[(3R)-1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]hepta-1,3,5-trienyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06416 |  | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | inquire | >95% | 0 |
| 06296 |  | Cy5(COOH)(SO3H) | 96,000/0.1mg | >95% | 0.9 |
| 05955 |  | Cy7-bis COOH | 64,600/0.2mg | >90% | 0.1 |
| 05940 |  | Cy5 dicarboxylic acid | 63,300/0.9mg | >95% | 0.5 |
| 05393 |  | Cy7-mono COOH | 64,600/0.1mg | >95% | 0.1 |
| 05148 |  | Sulfo-Cy3 bis(IAA) | 64,600/0.2mg | >95% | 0.1 |
| 05147 |  | Sulfo Cy3-diamine | 64,600/0.2mg | >95% | 5.0 |
| 05143 |  | Sulfo-Cy3 | 64,600/0.5mg | >95% | 2.6 |
| 05130 |  | Suflo-Cy3 | 63,300/0.9mg | >95% | 4.7 |
| 04910 |  | Mono-6-NH-Cy3-beta-cyclodextrin(maleimide-conjugation) | 96,000/0.1mg | <80% | 0.1 |
| 04162 |  | Mono-6-Cy3-NH-beta-cyclodextrin(amide-conjugation) | inquire | <80% | 0.1 |
| 01980 |  | Cy3-halolinker | 64,600/0.3mg | >95% | 0.1 |
